#United States #Drug Development #Ascendia Pharmaceuticals #CDMO #North Brunswick

Ascendia Pharmaceutical Solutions Launches New Brand Identity

In a notable shift within the pharmaceutical landscape, Ascendia Pharmaceuticals has officially rebranded itself as Ascendia Pharmaceutical Solutions. This change reflects over a decade of growth and transformation. The founder and CEO, Jim Huang, Ph.D., made the announcement, highlighting the company's expanded role in the pharmaceutical contract development and manufacturing organization (CDMO) sector.

The journey of Ascendia began 13 years ago with a small team focused on providing specialized formulation services for poorly soluble drugs. Over the years, it has grown to include a diverse group of over 50 seasoned professionals committed to advancing drug formulation from preclinical phases to commercial readiness. Dr. Huang emphasized that the new name encapsulates the company’s identity and the solutions it offers to its clients, while also illustrating its future trajectory.

Comprehensive Drug Development Services

Ascendia Pharmaceutical Solutions offers a robust suite of development services tailored to biopharma companies. The company is equipped to handle a variety of dosage forms, enhancing bioavailability and solubility through its state-of-the-art proprietary nanotechnologies, including AmorSol®, EmulSol®, LipidSol™, and NanoSol®.

Located in the New Jersey Bioscience Center, Ascendia operates within a sprawling 60,000-square-foot facility that features advanced cleanrooms and manufacturing suites compliant with cGMP (current Good Manufacturing Practice) standards. Here, they provide custom sterile and non-sterile formulations along with extensive analytical testing for various drug entities, including new chemical entities (NCEs), biologics, and complex dosage forms.

A Legacy of Quality and Innovation

Dr. Huang stated, "Our growth is built on the ability of our experienced scientific teams, proprietary technologies, and advanced manufacturing capabilities to consistently make the Impossible Possible." This commitment to innovation is underpinned by Ascendia’s BEST philosophy: Brilliant technology, Excellent service, Superior quality, and Trust - a framework that solidifies its reputation as a preferred partnership in the CDMO arena.

As Ascendia Pharmaceutical Solutions, the organization remains dedicated to fulfilling its mission of providing outstanding drug development services, ensuring that biotechnology and pharmaceutical companies can navigate the complexities of the drug development process efficiently.

In essence, the rebranding to Ascendia Pharmaceutical Solutions marks a significant milestone, showcasing the remarkable journey and future aspirations of a leading entity in the pharmaceutical sector. With its customer-centric culture and innovative solutions, Ascendia is poised to remain at the forefront of the industry, setting new benchmarks in drug development and manufacturing efficiency.

For more information on their range of services and advancements, visit the Ascendia Pharmaceutical Solutions official website.